The UroLift™ System is a proven minimally invasive procedure to treat an enlarged prostate. It is the only leading enlarged prostate procedure that does not require heating, cutting, or destruction of prostate tissue. The procedure is typically performed as a same-day outpatient procedure, including the office setting, under local anesthesia.1
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study
**When medical criteria are met
Indicated for the treatment of symptoms of an enlarged prostate up to 100 cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and/or the inability to control the urge.4 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Speak with your doctor to determine if you may be a candidate.
1. Shore, Can J Urol 2014, 2. Roehrborn, Can J Urol 2017, 3. Sonksen, EU Urol, 2015, 4. Roehrborn, J Urology 2013, 5. AUA BPH Guidelines 2003, 2020, 6. McVary, J Sex Med 2016
You may be a good candidate if you are a male, 45 years of age or older, and have symptoms relating to BPH. Speak with your urologist to see if the UroLift™ System treatment is right for you. If you have a known allergy to nickel, titanium or stainless steel, talk to your doctor about your allergy before getting a UroLift System treatment.
If you and your doctor decide that the UroLift™ System treatment is right for you, your doctor will provide you with more detailed information relating to the treatment. In general, the UroLift System is a minimally invasive treatment that entails minimal downtime. Your doctor will use the UroLift Delivery Device to deploy permanent implants to relieve obstruction caused by the enlarged prostate that is pressing on your urethra. The procedure, which usually takes less than an hour, may be performed under local or general anesthesia and you may be given medication to feel comfortable during the treatment. This typically helps minimize discomfort during the procedure, though everyone’s definition for pain and discomfort varies greatly. Typically, no catheter and no overnight stay is required post-treatment1.
After the treatment, patients typically go home the same day without a catheter. There is minimal downtime post-treatment and many patients experience symptom relief in as early as 2 weeks. Patients may experience some urinary discomfort during the recovery period. Most common side effects are mild to moderate and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge. Most symptoms resolved within two to four weeks after the procedure.
Clinical studies have shown the UroLift™ System treatment does not cause new, sustained instances of erectile or ejaculatory dysfunction.1 The same cannot always be said of other BPH therapies such as TURP, laser, and even medication.
The UroLift™ System treatment is covered by Medicare and many private insurers. Contact your insurance provider for your specific coverage information.
More Frequently Asked Questions
1. Roehrborn, J Urology 2013 LIFT Study
©2023 Teleflex Incorporated. All Rights Reserved. MAC01951-01 Rev B
GU Ohio Urology
